Catalyst Pharmaceuticals Announces FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy.
Muscular Dystrophy: FDA Approves Drug Developed By This Company
Muscular Dystrophy: FDA Approves Drug…
Muscular Dystrophy: FDA Approves Drug Developed By This Company
Catalyst Pharmaceuticals Announces FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy.